Chemotherapy directly followed by PARP inhibition as an alternative to surgery in patients with BRCA- mutated ovarian cancer – a potential management strategy in the era of COVID-19
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Monica Hagan Vetter, Stacy A. Smrz, Larry J. Copeland, David E. Cohn Tags: Letter to the Editors Source Type: research